Ceredex Value Advisors LLC acquired a new position in shares of Medical Properties Trust (NYSE:MPW) in the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm acquired 5,040,677 shares of the real estate investment trust’s stock, valued at approximately $66,789,000. Ceredex Value Advisors LLC owned 1.38% of Medical Properties Trust at the end of the most recent quarter.
A number of other hedge funds and other institutional investors have also made changes to their positions in the business. LSV Asset Management boosted its position in Medical Properties Trust by 4.8% during the 1st quarter. LSV Asset Management now owns 9,207,800 shares of the real estate investment trust’s stock worth $119,701,000 after acquiring an additional 419,700 shares during the period. Virtus Fund Advisers LLC boosted its position in Medical Properties Trust by 1.1% during the 4th quarter. Virtus Fund Advisers LLC now owns 4,618,450 shares of the real estate investment trust’s stock worth $64,753,000 after acquiring an additional 48,100 shares during the period. Earnest Partners LLC boosted its position in Medical Properties Trust by 24.8% during the 4th quarter. Earnest Partners LLC now owns 4,109,100 shares of the real estate investment trust’s stock worth $56,623,000 after acquiring an additional 816,225 shares during the period. Systematic Financial Management LP boosted its position in Medical Properties Trust by 52.9% during the 4th quarter. Systematic Financial Management LP now owns 3,661,337 shares of the real estate investment trust’s stock worth $50,453,000 after acquiring an additional 1,266,794 shares during the period. Finally, Wells Fargo & Company MN boosted its position in Medical Properties Trust by 8.0% during the 4th quarter. Wells Fargo & Company MN now owns 3,197,145 shares of the real estate investment trust’s stock worth $44,056,000 after acquiring an additional 238,055 shares during the period. Hedge funds and other institutional investors own 80.15% of the company’s stock.
MPW has been the subject of a number of research reports. Deutsche Bank decreased their price objective on Medical Properties Trust from $13.50 to $13.00 and set a “hold” rating for the company in a research report on Monday, March 19th. ValuEngine lowered Medical Properties Trust from a “buy” rating to a “hold” rating in a research report on Monday, April 2nd. Finally, Zacks Investment Research lowered Medical Properties Trust from a “hold” rating to a “sell” rating in a research report on Wednesday, April 18th. Eight analysts have rated the stock with a hold rating and four have issued a buy rating to the company. The company has a consensus rating of “Hold” and a consensus price target of $14.28.
Shares of Medical Properties Trust opened at $13.08 on Friday, MarketBeat.com reports. The stock has a market cap of $4.80 billion, a PE ratio of 9.69, a PEG ratio of 2.47 and a beta of 0.69. The company has a debt-to-equity ratio of 1.27, a current ratio of 2.04 and a quick ratio of 2.04. Medical Properties Trust has a 52-week low of $13.15 and a 52-week high of $13.31.
Medical Properties Trust (NYSE:MPW) last announced its quarterly earnings results on Thursday, May 3rd. The real estate investment trust reported $0.25 earnings per share (EPS) for the quarter, missing the Thomson Reuters’ consensus estimate of $0.36 by ($0.11). The firm had revenue of $205.05 million for the quarter, compared to analyst estimates of $204.70 million. Medical Properties Trust had a net margin of 41.47% and a return on equity of 8.14%. The firm’s quarterly revenue was up 31.1% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $0.33 earnings per share. equities analysts expect that Medical Properties Trust will post 1.43 earnings per share for the current fiscal year.
In other news, Chairman Edward K. Aldag, Jr. sold 116,216 shares of Medical Properties Trust stock in a transaction dated Tuesday, March 27th. The stock was sold at an average price of $12.56, for a total transaction of $1,459,672.96. Following the completion of the sale, the chairman now directly owns 1,759,620 shares in the company, valued at approximately $22,100,827.20. The sale was disclosed in a filing with the SEC, which can be accessed through this link. 1.00% of the stock is owned by insiders.
About Medical Properties Trust
Medical Properties Trust, Inc is a self-advised real estate investment trust formed to capitalize on the changing trends in healthcare delivery by acquiring and developing net-leased healthcare facilities. MPT's financing model helps facilitate acquisitions and recapitalizations and allows operators of hospitals and other healthcare facilities to unlock the value of their real estate assets to fund facility improvements, technology upgrades and other investments in operations.
Receive News & Ratings for Medical Properties Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medical Properties Trust and related companies with MarketBeat.com's FREE daily email newsletter.